FMI opines that the care pathway variance analytics market was valued at USD 1.8 billion in 2025. Demand is expected to advance to USD 2.1 billion in 2026 and USD 9.7 billion by 2036. Software is poised to lead by Component with 62.0% share in 2026, and Clinical Variance Analysis is forecast to lead by Application in 2026.